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Abstract
Background: Reliable, valid, and easy-to-administer instruments to identify possible caseness and to provide
proxies for clinical diagnoses are needed in epidemiological research on child and adolescent mental health.
The aim of this study is to provide further validity data for a parent telephone interview focused on Autism - Tics,
Attention-deficit/hyperactivity disorder (AD/HD), and other Comorbidities (A-TAC), for which reliability and prelimin-
ary validation data have been previously reported.
Methods: Parents of 91 children clinically diagnosed at a specialized Child Neuropsychiatric Clinic, 366 control
children and 319 children for whom clinical diagnoses had been previously assigned were interviewed by the A-
TAC over the phone. Interviewers were blind to clinical information. Different scores from the A-TAC were
compared to the diagnostic outcome.
Results: Areas under ROC curves for interview scores as predictors of clinical diagnoses were around 0.95 for most
disorders, including autism spectrum disorders (ASDs), attention deficit/hyperactivity disorder (AD/HD), tic disorders,
developmental coordination disorders (DCD) and learning disorders, indicating excellent screening properties.
Screening cut-off scores with sensitivities above 0.90 (0.95 for ASD and AD/HD) were established for most
conditions, as well as cut-off scores to identify proxies to clinical diagnoses with specificities above 0.90 (0.95 for
ASD and AD/HD).
Conclusions: The previously reported validity of the A-TAC was supported by this larger replication study using
broader scales from the A-TAC-items and a larger number of diagnostic categories. Short versions of algorithms
worked as well as larger. Different cut-off levels for screening versus identifying proxies for clinical diagnoses are
warranted. Data on the validity for mood problems and oppositional defiant/conduct problems are still lacking.
Although the A-TAC is principally intended for epidemiological research and general investigations, the instrument
may be useful as a tool to collect information in clinical practice as well.
Background
The “Autism - Tics, AD/HD and other Comorbidities
inventory” (A-TAC) is a comprehensive screening inter-
view for autism spectrum disorders (ASDs), attention
deficit/hyperactivity disorder (AD/HD), tic disorders
(TD), developmental coordination disorder (DCD),
learning disorders (LD) and other childhood mental
disorders that have been associated with these neurode-
velopmental disorders in the existing literature. The A-
TAC has previously been evaluated for reliability and
validity as a parent telephone interview among clinically
diagnosed children [1]. It has also been tested in the
general population [2]. Today, the A-TAC is unique in
combining good screening properties (high sensitivity)
with a high specificity in order to provide proxies for
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scale epidemiological research.
To date, disorders in this field have usually been stu-
died as categorical, discrete disorders. This may not be
an optimal approach. First, the diagnostic definitions
may not correspond to real categories. A taxonomic dis-
tribution has never been empirically demonstrated for
any of the major child and adolescent psychiatric disor-
ders. Second, these disorders rarely exist in “pure”
forms, i.e. without co-existing symptoms from other
diagnostic categories [3-5]. It may, in effect, be more
reasonable to regard these “conditions” as the lowermost
extremes of normally distributed neuropsychological
abilities, such as empathy, attention, impulse and motor
control.
The overlap across the ASDs, AD/HD, TD, DCD and
LD is considerable [6-8]. In subgroups, considerable
overlaps between the ASDs, the other neurodevelop-
mental disorders and obsessive compulsive disorder
(OCD) [9], eating disorders, including anorexia nervosa
(AN) [10], conduct disorder (CD), oppositional defiant
disorder (ODD) [11], and LD [12], have also been
reported. The A-TAC is to date the only screening
instrument to address this array of coexisting condi-
tions, even though other screening instruments for
ASDs have been established, such as the CHAT (Check-
list for Autism in Toddlers) [13], ASSQ (Asperger Syn-
drome Screening Questionnaire) [14], ASQ (Autism
Screening Questionnaire) [15], and some new instru-
ments that assess a broader notion of features associated
with ASD, such as the AQ (Autism Quotient) [16], and
SRS (The Social Reciprocity Scale) [17]. These instru-
ments, however, generally focus on the ASD without
systematically tapping into any of co-existing disorders.
The first aim of the present study was to replicate the
previously documented good-excellent screening proper-
ties of the A-TAC for ASD, AD/HD, TD, DCD and LD
[1] in a new study group with a substantially larger con-
trol group. The second aim was to identify algorithms
with high specificity in order to provide proxies for clin-
ical diagnoses.
Methods
Development and design of the A-TAC
The A-TAC telephone interview is based on a screening
questionnaire developed at the Institute of Neuroscience
and Physiology, Child and Adolescent Psychiatry, Uni-
versity of Gothenburg, for the purpose of screening gen-
eral populations in research on child mental health. It is
an open access instrument for researchers and clinicians
in the field, available in English as extra material to this
paper (Additional file 1).
The A-TAC is also freely available from the website of
the Swedish Child Neuropsychiatry Science Foundation
http://www.childnps.se/, together with a detailed
description of the psychometric development of the
instrument [18]. Posted on the web site are also transla-
tions of the original Swedish A-TAC into English,
French, and Spanish (ASD modules only), translated by
the authors and/or back-translated for authors’ approval.
The A-TAC items are organized in modules (e.g.,
attention, impulsiveness and activity, social interaction,
communication), targeting hypothetical areas of psychia-
tric and psychological problems based on theoretical
assumptions and the clinical literature in the field. By
these modules, the A-TAC yields dimensional ratings of
(1.) the number of symptoms endorsed, and (2.) the pro-
blem load in each module, together assessing a broad
range of possibly overlapping neurodevelopmental and
psychiatric problem constellations. The A-TAC covers
almost verbatim the specific problems included in the
DSM-IV diagnostic definitions of disorders such as
a u t i s t i cd i s o r d e r ,A D / H D ,D C D ,T Da n dL D[ 1 9 ] ,b u t
also a selection of DSM-IV symptoms listed for other
co-existing psychiatric problems, such as AN, OCD,
ODD, CD, depression, separation anxiety and psychosis.
Additional items include symptoms from the Gillberg &
Gillberg algorithm for Asperger Syndrome [20] and
questions or aspects included in published question-
naires for screening or diagnostics of ASDs and general
psychiatric disorders, such as the ASSQ [14], the ASDI
(Asperger Syndrome Diagnostic Interview) [21], and the
FTF (Five to Fifteen questionnaire) [22]. The content
validity of the items is supported by their close relation
to established criteria and by the authors’ clinical exper-
tise in the field.
In a clinical validation based on telephone interviews
with 111 parents of clinically diagnosed children and
healthy controls [1], a preliminary version of the A-TAC
(with 178 items) had “excellent” screening properties for
AD/HD and ASD (as assessed by areas under receiver
operating characteristics curves around 0.90), and “fair”
screening properties for LD, DCD, and TD (as assessed
by areas under receiver operating characteristics curves
between 0.70 and 0.80). The algorithms based on the
DSM-IV criteria were sufficient for screening purposes,
and items added from other sources did not improve
the prediction of caseness. Inter-rater and test-retest
reliability coefficients were good-excellent (intra-class
coefficients ranging from 0.97 to 1.0 and from 0.77 to
0.97 respectively, with the exception of eating problems
0.57. The astonishing inter-rater correlations was, of
course, due to the two raters participating in a simulta-
neous telephone interview and demonstrate little more
than the clear conceptualization of the response
alternatives.
This version was later extended to the present A-TAC
by adding a large number of items (to a maximum of
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tion, suffering, age at onset, remission and duration
repeated for each module) and subsequently pruning the
instrument following psychometric considerations by
removing 68 items that reduced internal consistency
within the modules and organising the others according
to a “gate” structure, identifying systematically those
items that were needed to identify all cases for whom
an impaired functioning and/or suffering related to
those items in the module were reported (details given
at the cited web site) [18]. The final version of the A-
TAC (Full Version, FV) thus consists of (i) 96 “gate”
items used for basic screening and identification of
proxies to diagnoses, organised in different modules, (ii)
163 additional items tapping into more specific symp-
toms, and (iii) 72 items (4 in each module) addressing
psychosocial dysfunction and subjective suffering asso-
ciated with that particular problem area, the age at
onset and whether the problems are still present or in
remission. The motive for establishing the “gate” struc-
ture is, of course, to developab r i e f e ri n s t r u m e n tw i t h
as good screening and diagnostic properties as the
longer, more detailed, full version. The additional items
a r eo n l ya s k e di fo n eo rm o r eo ft h ef i r s ti t e m si nt h e
module are endorsed fully or to some extent. An exam-
ple of a module, with the introductory remarks, gate
structure, additional questions and conclusion, is given
in Figure 1. A version containing the gate items only
(Short Version, SV) is also included in the additional
material to this paper (Additional file 2). The A-TAC
modules are: Communication, Social interaction, Flex-
ibility (corresponding to the problem domains of ASD),
Attention, Hyperactivity (corresponding to AD/HD),
Motor coordination, Perception, Learning, Executive
functioning, Tics, Compulsions/obsessions, Feeding,
Separation, Anxiety, Opposition/conduct, Mood and Con-
cept of reality.
The interview is highly structured with three possible
answers for each item (yes, scored as 1; yes to some
extent, scored as 0.5; and no, scored as 0).
In the present study, all interviews with clinical cases
and controls included all A-TAC items without “gates”
t oe x c l u d eq u e s t i o n s .W ew e r et h e r e f o r ea b l et oc o m -
pare the psychometric properties of scores derived from
either the shorter gate items ("gate score”)o rf r o mt h e
sum of all items in modules ("sum score”). For each
module in which at least one item was answered in the
affirmative, the parents were also asked about whether
or not the endorsed symptoms had led to (1) dysfunc-
tion at school, among peers, or at home, and (2) suffer-
ing on the part of the child. A “problem load score” was
calculated as the sum of these two items (thus ranging
from 0 to 2), with a theoretically defined cut-off for pro-
blems to be considered “significant” at ≥ 1, indicating
either that one of the problem questions was fully
endorsed or that both were endorsed “to some extent”.
In order to be considered valid, information for at least
one of the items was required. Finally, for each symp-
tom/problem endorsed, age of onset, persistence and
age of an eventual remission were documented.
The A-TAC telephone interview is intended for use
with parents as informants and lay persons with brief
training as interviewers. Each module is preceded by a
short introduction to inform the parent that the inter-
view concerns problems or difficulties that the child is
either experiencing at the present time or has experi-
enced earlier in life, and that problems or peculiarities
must be/have been pronounced as compared to other
children in the same age group in order to be endorsed.
The full A-TAC interviews used here took on average
32 minutes to conduct.
Participants
Clinical cases
Letters were sent out to the parents of consecutively
referred children and adolescents, aged between six and
19 years, who were waiting for or were undergoing a
neuropsychiatric investigation at the Child Neuropsy-
chiatric Clinic (CNC, the university hospital clinic
affiliated with the University of Gothenburg), asking
whether they consented to participate in this validation
study. We aimed at a study group of 100 subjects. One
hundred and six parents accepted while 65 declined. Of
the 106 parents who accepted five were initially
excluded, two based on language/communication pro-
blems, one because contact information was lacking,
one as the consent was withdrawn once the interview
had started and one due to a hearing disorder. Of the
101 children/adolescents who remained eligible, it was
possible to interview 91 fully while 10 dropped out of
the study due to various contact problems, changed cir-
cumstances over time or practical difficulties to actually
carry out the full interview. This group of 91 inter-
viewed children and adolescents, referred to as the
“Clinical sample”,c o n s i s t e do f7 1b o y s ,2 0g i r l s ,w i t ha
mean aged of 11.7 years old (range 6 to 19 year), and
was considered representative for the patient group seen
at the clinic.
Comparison groups
Controls
From the ongoing Child and Adolescent Twin Study in
Sweden (CATSS) [23], a subsample of 165 nine-years-
olds (84 boys and 81 girls) and 201 twelwe-years-olds
(97 boys and 104 girls, totalling 366 children) were iden-
tified as controls from the pilot study of the CATSS.
Children being representative of the population group
without mental health problems severe enough to have
warranted specific diagnoses. These controls did not
undergo any clinical evaluation in connection with the
Larson et al. BMC Psychiatry 2010, 10:1
http://www.biomedcentral.com/1471-244X/10/1
Page 3 of 11present study but as their parents had answered by the
negative to questions about previous clinical contacts,
including a comprehensive list of psychiatric diagnoses:
A D / H D ,A N ,A S D ,A s p e r g e r ,a u t i s m ,b u l i m i a ,C e r e b r a l
Palsy (CP), Deficits in Attention, Motor control and Per-
ception (DAMP), DCD, depression, dyslexia, hyperactiv-
ity, motor tics, vocal tics, Tourette syndrome, Minimal
Brain Dysfunction (MBD), panic, separation, compulsive
acts, obsessions, anxiety, and mental retardation, this
group will be referred to as “controls”.
Community recruited sample
We further identified 122 nine-years-olds (89 boys and
33 girls) and 197 twelwe-years-olds (141 boys and 56
girls) totalling 319 children from the CATSS for whom
the parents had in fact endorsed one or several psychia-
tric diagnoses when asked by the same structured list.
Figure 1 The A-TAC inventory. The Social interaction module of the A-TAC full version, illustrating the gate structure, the additional clinical
questions and the final questions on impairment, suffering, age at onset and remission.
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sample”.
Procedures
All interviews were conducted over the telephone. The
first author (TL), at the time a graduate student in psy-
chology, who was blind to all diagnostic information
and clinical data on the children, interviewed the par-
ents of all children from the CNC, using a paper-and-
pencil questionnaire. Parents were specifically asked not
to provide any further information about their children,
in order not to jeopardize blindness.
The CATSS interviews were performed by a profes-
sional interview company, Intervjubolaget, by inter-
viewers who had had a brief introduction in child and
adolescent psychiatry and twin research, as detailed else-
where [18]. They followed a computerized version of the
A-TAC, and all responses were entered directly on to a
database.
Diagnostic process
Clinical diagnoses assigned during investigations at the
CNC were based on medical history, physical examina-
tion including a neuromotor assessment and extensive
clinical interviews with parents and children, by a physi-
cian with expertise in the field of neuropsychiatry, and
psychological examination by a trained neuropsycholo-
gist. In all children, an assessment of the cognitive level
was made with a mental age appropriate test battery
[24-27]. Children with significant school achievement
problems were also examined by an educational specia-
list using tests of reading/writing skills, observation of
the child in the school setting, and interviews with the
child’s teachers about school performance and beha-
viour. All children had diagnoses based on structured
instruments, such as the ADI-R (Autism Diagnostic
Interview Revised) [28], DISCO (Diagnostic Interview
for Social and Communication Disorders) [29,30], CARS
(Childhood Autism Rating Scale) [31], ASDI [21], and/
or ADHD-RS (ADHD Symptom Rating Scale) [32], even
though instruments were never the sole basis for a diag-
nosis. The physician in charge for each case was asked
to complete a diagnostic protocol specifying all possible
co-existing diagnoses according to the DSM-IV criteria.
A senior expert in child neuropsychiatry (CaG) subse-
quently scrutinized all medical records and established
final clinical diagnoses according to the DSM-IV opera-
tional criteria based on all the available information. By
using these final diagnoses for the analyses in this paper
we avoided diagnostic differences between the various
psychiatrists involved in the clinical diagnostic investiga-
tions. Hierarchical criteria excluding co-existing condi-
tions, such as AD/HD in cases assigned a diagnosis in
the autism spectrum or considerations of conditions
being “better explained” by other disorders were
disregarded in order to account for the true range of
co-existenee across diagnostic categories.
Ethical considerations
The study was carried out in accordance with the
Declaration of Helsinki and approved by the Ethical
Committee at the University of Gothenburg (No. Ö633-
03) with an extension for this particular study, and the
community sample and control group were covered by
the ethical approval for the twin project Child and Ado-
lescent Twin Study in Sweden by the ethical committee
at the Karolinska Institute (No. 02-289). All analyses
were performed on anonymized data files.
Statistical analyses
B a s e do nt h ec o d e da n s w e r s ,t h ef o l l o w i n gs c o r e sw e r e
calculated for each module: a “sum” score including all
items in the module, a “gate” s c o r eb a s e do nt h ep r e -
viously established “gate structure” for each module,
and, for the five validated modules from the preliminary
validation by Hansson et al. [1] a “validated/DSM-IV”
score according to the items included in the previous
publication. Finally, the “problem load score” was calcu-
lated based on the two items reporting suffering and/or
psychosocial dysfunction.
The scores were first compared to the diagnostic eva-
luations through receiver operating characteristics
(ROC) curves, where the clinical diagnoses were depen-
dent variables and the interview scores independent pre-
dictors. The area under the curve (AUC) is a measure of
the overall predictive validity of the instrument where
AUC = 0.50 signals random prediction, 0.60 < AUC ≤
0.70 poor, 0.70 < AUC ≤ 0.80 fair, 0.80 < AUC ≤ 0.90
good and AUC > 0.90 excellent validity [33]. Following
the plots of sensitivity and 1-specificity at all possible
cut-off scores provided by the ROC analyses, we identi-
fied the highest possible cut-off that yielded a sensitivity
≥ 0.90 (for screening purposes) and the lowest cut-off
that yielded a specificity ≥ 0.90 (for identification of
caseness). For ASD and AD/HD, the required levels of
sensitivity and specificity were put at 0.95. In a final
step, we assessed the prevalences of cases that met these
cut-off levels among the controls.
All statistics were calculated by the SPSS software
package 14.0 using a two-tailed significance level of p <
0.05.
Results
1. Basic comparison of screening properties
The prevalences of the targeted disorders in the clinical
and community samples are given in Table 1. ROC
AUCs were calculated first for the clinically diagnosed
children and the controls, and, in a second step, for the
whole study group including both the clinical and the
community samples (Table 1, with examples for module
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A-TAC module Diagnostic category Prevalence in:
Clinical sample (N = 91)
Community sample (N = 319)
Validated DSM-IV
items
Gate score Sum score
Language, Social interaction and Flexibility Autism N = 48 (53%) 0.96 0.96 0.96
spectrum (0.94-0.98) (0.94-0.98) (0.94-0.97)
disorder N = 117 (37%) 0.92 0.92 0.91
(0.89-0.94) (0.89-0.93) (0.88-0.93)
Language Autism 0.89 0.92 0.92
spectrum (0.85-0.95) (0.88-0.96) (0.87-0.95)
disorder 0.87 0.87 0.87
(0.83-0.90) (0.84-0.91) (0.87-0.89)
Social interaction Autism 0.96 0.95 0.96
spectrum (0.94-0.98) (0.93-0.97) (0.94-0.98)
disorder 0.88 0.88 0.89
(0.85-0.92) (0.85-0.91) (0.86-0.92)
Flexibility Autism 0.92 0.94 0.94
spectrum (0.87-0.96) (0.92-0.97) (0.92-0.97)
disorder 0.87 0.89 0.89
(0.83-0.90) (0.86-0.92) (0.86-0.92)
Attention, hyperactivity AD/HD N = 53 (58%) 0.94 0.94 0.95
(0.92-0.97) (0.92-0.96) (0.93-0.97)
N = 154 (48%) 0.90 0.90 0.90
(0.88-0.92) (0.87-0.92) (0.88-0.92)
Concentration and attention AD/HD 0.94 0.94 0.95
(0.92-0.96) (0.92-0.96) (0.93-0.97)
0.88 0.88 0.89
(0.85-0.91) (0.85-0.91) (0.86-0.91)
Hyperactivity AD/HD 0.88 0.88 0.88
(0.82-0.93) (0.83-0.93) (0.83-0.93)
0.86 0.86 0.86
(0.83-0.90) (0.83-0.90) (0.83-0.90)
Motor coordination DCD N = 46 (50%) 0.78 0.72 0.78
(0.70-0.86) (0.64-0.81) (0.71-0.86)
N = 57 (18%) 0.68 0.65 0.68
(0.61-0.75) (0.59-0.74) (0.63-0.77)
Perception DAMP N = 45 (49%) 0.87 0.93
(0.81-0.93) (0.90-0.96)
N = 62 (19%) 0.78 0.82
(0.72-0.83) (0.78-0.87)
Learning Mental N = 16 (18%) 0.87 0.89 0.89
retardation 0.82-0.93) (0.85-0.94) (0.85-0.93)
N = 49 (15%) 0.80 0.85 0.81
(0.75-0.85) (0.80-0.90) (0.77-0.87)
Planning and organizing tasks AD/HD N = 53 (58%) 0.90 0.93
(0.86-0.93) (0.90-0.95)
N = 154 (48%) 0.80 0.83
(0.77-0.84) (0.80-0.87)
Tics Tic N = 13 (14%) 0.97 0.97 0.98
disorder (0.94-0.99) (0.93-1.0) (0.96-0.99)
N = 24 (7%) 0.92 0.94 0.94
(0.87-0.98) (0.94-0.98) (0.91-0.97)
Areas under Receiver Operating Characteristics Curves using the three different A-TAC scales (DSM-IV items, Gate items and Sum scores) as predictors of the
diagnoses specified in the second column using first the clinical sample and controls, and then both the clinical and the community samples and the controls
(data for both sexes is given in this Table, while data for boys only are given in Table 2 and for girls only in Table 3).
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Figures 2 and 3). Overall, the “gate” scores performed as
w e l la st h ep r e v i o u s l yu s e d“validated/DSM-IV” scores
or the “sum” scores including the items included below
the “gates”.T h e“problem load scores” performed less
well (data not shown) and were therefore excluded from
further analyses. The screening properties previously
reported for ASD, AD/HD, TD, DCD and CD were all
replicated, and in most cases considerably improved in
the present study. New screening algorithms could be
established for perceptual problems as defined by the
DAMP concept, and executive functioning in the AD/
HD diagnosis. The confidence intervals for the AUCs
f o rA S D ,A D / H D ,D C D ,p e r c e p t i o n - D A M P ,l e a r n i n g ,
executive functioning-AD/HD, tics all differed from the
random 0.5 AUC (p < 0.001).
All analyses were remade separately for boys and girls
both with both the clinical and community samples as
specified in Table 2 (Boys) and Table 3 (Girls). Gener-
ally, the small number of girls gave the higher AUCs,
Figure 2 Receiver Operating Characteristics for Autism Spectrum Disorders. ROC curves to illustrate the predictive ability of the gate
("GRIND”) scores from the three modules (H, I & J) and their sum for ASDs among Clinical sample and controls.
Figure 3 Receiver Operating Characteristics for AD/HD. ROC curves to illustrate the predictive ability of the gate ("GRIND”)s c o r e sf r o mt h e
two modules (C & D) and their sum for AD/HD among Clinical sample and controls.
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for the collapsed gender groups.
The ROC analyses for ASDs were recalculated for the
34 clinical subjects who had ASD diagnoses with a nor-
mal intelligence and controls in order to check for a
possible bias by comorbid mental retardation that could
have conferred unspecific group differences across many
modules, but these analyses yielding very similar AUCs
(e.g. for the module gate scores 0.90, 0.95 and 0.94 in
the order of the tables and for the total ASD score 0.95).
2. Cut-off scores, sensitivity and specificity
Final cut-offs were established based on the “gate”
scores. Sensitivity, specificity and prevalence among the
controls for these cut-offs are given in Table 4. We also
tested the cut-offs in the whole study group with the
parent-reported diagnoses from the community sample.
The sensitivities and specificities in this larger group
were lower but still acceptable, as seen in the table. For
ASD and AD/HD, very high sensitivities and specificities
could be reached.
Table 2 Areas under Receiver Operating Characteristics Curves for boys only.
A-TAC module Diagnostic category Prevalence in:
Clinical sample (N = 71)
Community sample (N = 230)
Validated
DSM-IV items
Gate score Sum score
Language, Social interaction and Flexibility Autism N = 40 (56%) 0.94 0.93 0.93
spectrum N = 93 (40%) 0.90 0.89 0.89
disorder
Attention, hyperactivity AD/HD N = 42 (59%) 0.91 0.91 0.91
N = 127 (55%) 0.87 0.87 0.87
Motor coordination DCD N = 39 (55%) 0.78 0.70 0.76
N = 47 (20%) 0.63 0.61 0.63
Perception DAMP N = 36 (51%) 0.83 0.90
N = 53 (23%) 0.73 0.77
Learning Mental N = 12 (17%) 0.83 0.87 0.85
retardation N = 37 (16%) 0.76 0.83 0.76
Planning and organizing tasks AD/HD N = 42 (59%) 0.86 0.89
N = 127 (55%) 0.76 0.79
Tics Tic disorder N = 11 (15%) 0.95 0.95 0.97
N = 22 (10%) 0.81 0.92 0.92
Table 3 Areas under Receiver Operating Characteristics Curves for girls only.
A-TAC module Diagnostic
category
Prevalence in:
Clinical sample (N = 20)
Community sample (N =
89)
Validated DSM-IV
items
Gate score Sum score
Language, Social interaction and
Flexibility
Autism N = 8 (40%) 0.99 0.99 0.98
spectrum N = 24 (27%) 0.95 0.94 0.94
disorder
Attention, hyperactivity AD/HD N = 11 (55%) 0.98 0.98 0.99
N = 27 (30%) 0.93 0.93 0.93
Motor coordination DCD N = 7 (35%) 0.83 0.78 0.83
N = 10 (11%) 0.75 0.72 0.76
Perception DAMP N = 9 (45%) 0.94 0.97
N = 9 (10%) 0.88 0.93
Learning Mental N = 4 (20%) 0.94 0.92 0.94
retardation N = 12 (13%) 0.85 0.86 0.86
Planning and organizing tasks AD/HD N = 11 (55%) 0.97 0.98
N = 27 (30%) 0.88 0.91
Tics Tic disorder N = 2 (10%) 0.98 0.98 0.99
N = 2 (2%) 0.98 0.99 0.99
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The A-TAC appears to be a valid instrument to screen
for and to identify caseness of ASD and overlapping
neuropsychiatric/developmental disorders in childhood.
Previous non-clinical child and adolescent psychiatric
interviews have relied on empirically defined assess-
ments of problems in the general population, and, even
though such assessments have a strong evidence basis, it
remains problematic to interpret findings in clinical
terms, especially with regard to neuropsychiatric condi-
tions. The Childhood Behavior Checklist (CBCL) was
initially developed according to empirical considerations
[34], but has later been developed in accordance with
DSM-IV categories [35]. However, the relationship
between the items in this checklist and clinically
assigned diagnoses remains unclear [36]. In contrast,
more elaborate clinical, interview-based, diagnostic sche-
dules, such as the Kiddie-SADS (Kiddie-Schedule for
Affective Disorders and Schizophrenia) [37], and the
DISCO [30] may provide precise clinical diagnoses, but
are less useful in non-clinical research. In general, they
also focus on specific diagnoses without accounting for
dimensionality or the complexity of co-existing pro-
blems. In the previously reported preliminary validation,
the A-TAC inventory was very reliable in terms of
inter-rater (as expected since the interview is highly
structured and the ratings were simultaneous) and test-
retest agreement. Its usefulness in large-scaled epide-
miological research is obvious, but it may also be a tool
in the clinic, for example in screening referred children
waiting for clinical appointments, and providing struc-
tured information before consultations, or for possibly
afflicted family members. The present study has
provided data on a broader range of associate conditions
and presented validity measures for these, even if they
are sometimes based on very small numbers of diag-
nosed children in relation to children who did not meet
criteria for these conditions.
Screening properties were not improved by adding
more items, and the “gate” scores seem sufficient to
identify children with clinical diagnoses (sensitivities
well above 0.90). Addition of new items did not improve
general specificity even if they provide notable clinical
information about problems present in the target
children.
The shortest predictive strategy to identify DSM-IV-
disorders was the item constellations based on the
DSM-IV-criteria only. This is not surprising as the
dependent variable was defined in terms of DSM-IV
disorders. Additional items may provide clinical infor-
mation that is relevant in other contexts but the addi-
tion of the “gate” items or the “sum” score items did
not improve the prediction of DSM-IV diagnoses spe-
cifically. As the “gate” algorithms are not much longer
than the DSM-IV scales and were developed in order
to increase the number of screen positive children
among those who had previously identified problems,
w ew i l lu s et h e s ei nt h ef i n a lv e r s i o n so ft h ei n s t r u -
ment. In the full version, the items “under the gates”
were kept in order to provide clinically relevant infor-
mation but may be omitted if the purpose of interview
is purely screening. For this, we have also made a
short version, which contains the “gate” items only
(Additional file 2).
Among instruments that are possible to use in large-
scale, non-clinical research, the A-TAC is unique in that
Table 4 Sensitivity and Specificity
Diagnostic Category A-TAC Scale Cut Off Sensitivity/Specificity:
Clinical sample and
Control group
Sensitivity/Specificity:
Clinical, Community samples and Control group
Autism spectrum disorder Gate items 4.5 0.96/0.88 0.91/0.80
8.5 0.71/0.95 0.61/0.91
AD/HD Gate items 6.0 0.98/0.81 0.91/0.73
12.5 0.52/0.95 0.56/0.93
Motor coordination Gate items 0.5 0.59/0.85 0.63/0.68
1 0.28/0.95 0.32/0.87
Perception Gate items 0.5 0.91/0.62 0.92/0.46
2.5 0.62/0.93 0.55/0.83
Learning* Gate items 1.0 0.88/0.75 0.92/0.60
3.0 0.23/0.96 0.41/0.93
Planning & organizing tasks Gate items 1.0 0.91/0.80 0.82/0.70
1.5 0.64/0.91 0.54/0.85
Tics Gate items 1.5 0.92/0.90 0.875/0.86
*) cut-off values determined by the large group
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Page 9 of 11it (a) identifies caseness across a range of different diag-
nostic categories, (b) provides dimensional assessments
specifically in relation to ASD symptomatology and
associated problems, and (c) in that it has been validated
as a telephone interview. There are today several instru-
ments that are frequently used as telephone interviewing
tools, but are not validated as such. In the clinic, the A-
TAC may for instance be used as an easy way to obtain
structured information from parents before clinical
examinations, making it possible to quickly focus on the
most relevant aspects of the child’s mental and/or beha-
vioural problems.
Limitations
The study has several limitations. The attrition rate in
the clinical study was high. A considerable number of
parents never contacted after the first letters had been
sent out, which might be explained by the extremely
long waiting times for this kind of assessments in Swe-
den. It was also difficult to include all the patients who
gave consent to the studies; it was hard to get in con-
tact with many of these parents and to conduct a tele-
phone interview with them. The clinical diagnoses are
state of the art but in the extended group of parent-
identified children, we have relied on parent informa-
tion about clinical diagnosis. However, there were no
substantial differences between the results in the clini-
cally investigated group and the parent-identified
group.
Conclusions
The A-TAC is a sensitive tool to screen for autism spec-
trum disorders, AD/HD, tics, learning disorders, and
developmental coordination disorders, which does not
require expert interviewers. The number of symptoms
affirmed in the A-TAC may be used as a dimensional
measure of the probability of a clinical diagnosis, and
specific algorithms for identifying caseness with a high
specificity have been developed.
Additional file 1: A-TAC: FV. The A-TAC full version consists of 96
questions asked of all interviewees and 163 additional, branched
questions, which are only asked if one or more of the items above the
gates is endorsed. This “gate structure” renders the A-TAC useful and
easily administered in large population based studies, as well as in
clinical assessment.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-244X-10-1-
S1.DOC]
Additional file 2: A-TAC: SV. A shortened version of the A-TAC with
only the “gate” items to identify children with significant problems. This
short version may provide an important tool for use in large-scale
epidemiological studies, as well as in clinical screening.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-244X-10-1-
S2.DOC]
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